




|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||

WIKI ANALYSIS
|
Bioheart, BHRT, is a Sunrise, Florida Biotech company that is developing autologous cell therapies to treat chronic and acute heart disease. In essence autologous cell therapies purify and amplify subpopulations of patients own cells to replace missing or damaged tissue, such as heart muscle. This type of treatment is standard for multiple myeloma, a common cancer. BHRT is set to debut on the NASDAQ between $6-8.




| ||||||
